|
Systemic Lupus Erythematosus and Autoimmunity
Citations 371-380 of 461 total displayed.
|
Past content
(since Jan 2000):
|
- Original Papers
Prevalence of antineutrophil cytoplasmic autoantibodies in patients with tuberculosis
- L. F. Flores-Suárez, J. Cabiedes, A. R. Villa, F. J. van der Woude, and J. Alcocer-Varela
Rheumatology 2003; 42: 223-229.
[Abstract]
[Full Text]
- Original Papers
Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems
- S. M. Sultan, S. Begum, and D. A. Isenberg
Rheumatology 2003; 42: 230-234.
[Abstract]
[Full Text]
- Original Papers
Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients
- E. Drewe, E. M. McDermott, P. T. Powell, J. D. Isaacs, and R. J. Powell
Rheumatology 2003; 42: 235-239.
[Abstract]
[Full Text]
- Original Papers
Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus
- C.-S. Yee, H. Hussein, J. Skan, S. Bowman, D. Situnayake, and C. Gordon
Rheumatology 2003; 42: 276-279.
[Abstract]
[Full Text]
- Original Papers
Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study
- J. P. A. Ioannidis, G. E. Katsifis, E. D. Stavropoulos, M. N. Manoussakis, and H. M. Moutsopoulos
Rheumatology 2003; 42: 357-361.
[Abstract]
[Full Text]
- Letters to the Editor
Improvement of acquired partial lipodystrophy with rosiglitazone despite ongoing complement activation
- U. A. Walker, M. Kirschfink, and H. H. Peter
Rheumatology 2003; 42: 393-394.
[Extract]
[Full Text]
- Original Papers
The inducible nitric oxide synthase promoter polymorphism does not confer susceptibility to systemic lupus erythematosus
- M. Á. López-Nevot, L. Ramal, J. Jiménez-Alonso, and J. Martín
Rheumatology 2003; 42: 113-116.
[Abstract]
[Full Text]
- Original Papers
Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus
- C. Y. Ho, C. K. Wong, E. K. Li, L. S. Tam, and C. W. K. Lam
Rheumatology 2003; 42: 117-122.
[Abstract]
[Full Text]
- Original Papers
Autoantibodies to dsDNA cross-react with the arginine–glycine-rich domain of heterogeneous nuclear ribonucleoprotein A2 (hnRNP A2) and promote methylation of hnRNP A2
- K.-H. Sun, S.-J. Tang, Y.-S. Wang, W.-J. Lin, and R.-I. You
Rheumatology 2003; 42: 154-161.
[Abstract]
[Full Text]
- Letters to the Editor
Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjögren's syndrome
- A. Prabu, T. Marshall, C. Gordon, T. Plant, A. Bawendi, S. Heaton, S. Jobson, D Briggs, and S. J. Bowman
Rheumatology 2003; 42: 189-191.
[Extract]
[Full Text]
|
|
